Bayer applies for EU approval of menopause drug elinzanetant
Bayer has submitted a marketing authorisation application to the European Medicines Agency (EMA) for its menopause treatment elinzanetant. Bayer’s pill is indicated for the treatment of moderate to severe vasomotor symptoms – also known as hot flashes – …